DAR-901, an inactivated booster vaccine against tuberculosis, induces a humoral and cellular immune response against antigens, has an acceptable safety profile, and is well-tolerated, a new randomized controlled trial shows.
Higher residual gas volume is correlated with increased cross-sectional pulmonary artery (PA) area and may thus play a role in pulmonary hypertension in chronic obstructive pulmonary disease (COPD), reports a new study.
There is no evidence that the sex discordance in childhood asthma is narrowing, reports a new study. Particularly, there is a higher prevalence of asthma in males before puberty and in females after puberty.
Third-generation EGFR tyrosine kinase inhibitors (TKIs) designed to overcome the T790M mutation have been shown to double progression-free survival (PFS) of patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations, according to reports at the European Lung Cancer Conference (ELCC) 2016 held recently in Geneva, Switzerland.
Umeclidinium/vilanterol improves SGRQ total score and decreased rescue albuterol use in patients with chronic obstructive pulmonary disease (COPD), as observed in a 12-week multicentre, randomised, double-blind, parallel-group, placebo-controlled study.
Fluticasone furoate-vilanterol combination increases trough forced expiratory volume in 1 second compared with fluticasone furoate-fluticasone propionate in patients with symptomatic asthma, as stated in a systemic review with meta-analysis of seven published randomised clinical trials.